Skip to main content

Month: May 2023

New Long-Reaching USB 3.2 Compatible Reclocker/Redriver Devices for Automotive and Industrial Applications

Microchip’s EQCO510 and EQCO5X31 devices offer a solid two-channel solution to send high-speed data signals up to 15 meters in both directions CHANDLER, Ariz., May 16, 2023 (GLOBE NEWSWIRE) — The standard universal serial bus or USB connection is an industry mainstay that transfers data between two devices. The increase of adding electronic components to applications across the automotive, industrial and consumer industries has spurred the need for far-reaching USB cabling products. To provide long-distance and reliable USB solutions to the market, Microchip Technology (Nasdaq: MCHP) today announces two new reclocker/redriver devices. The automotive EQCO510 and industrial EQCO5X31 reclocker/redriver devices extend USB coverage up to 15 meters for maximum reach and are compatible with the USB 3.2 Generation 1 SuperSpeed protocol. The...

Continue reading

Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward

Cytek Aurora CS Cytek® has shipped its 100th Cytek Aurora CS system. Built on the same Full Spectrum Profiling™ technology comprising Cytek’s Aurora cell analysis system, the Aurora CS delivers high-sensitivity capabilities at the single-cell level to resolve and sort even the most challenging cell populations.FREMONT, Calif., May 16, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that it has shipped its 100thCytek Aurora CS system. This milestone is a clear indication of the company’s continuing momentum – and of the scientific community’s desire for Full Spectrum Profiling™ (FSP™) technology that streamlines workflows, accelerates discoveries and maximizes efficiency. Launched in June 2021, the Cytek Aurora CS is built on the same...

Continue reading

Reviv3 Announces Distribution Agreement with Kroll International for AXIL Hearing Protection and Enhancement Products

LOS ANGELES, May 16, 2023 (GLOBE NEWSWIRE) — Reviv3 Procare Company (“Reviv3” or the “Company”) (OTCQB: RVIV), an emerging global e-commerce consumer products company, entered into a distribution agreement with Kroll International, a leading wholesale distributor of law enforcement, public safety, military, homeland security, and shooting sports products, to distribute AXIL hearing enhancement and protection products. “We are excited to welcome Kroll to our family of partners,” said Reviv3 CEO Jeff Toghraie. “This agreement further expands our hearing enhancement and protection solutions in the vital public safety and security markets. I am grateful to the Kroll team for sharing our vision and to our AXIL innovation team for their continued commitment to bring enhanced capability hearing solutions to our customers.” AXIL...

Continue reading

Immutep Receives Positive Feedback from FDA on Late-Stage Clinical Development of Eftilagimod Alpha in Non-Small Cell Lung Cancer

Media Release SYDNEY, AUSTRALIA, May 16, 2023 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has received positive feedback from the US Food and Drug Administration (FDA), regarding the Company’s late-stage clinical development plans for its first-in-class soluble LAG-3 protein and MHC Class II agonist, eftilagimod alpha (“efti”), for the treatment of 1st line non-small cell lung cancer (NSCLC). The FDA is supportive of a registrational trial to evaluate efti in combination with an anti-PD-1 therapy based on the encouraging data from the Phase II TACTI-002, Part A (N=114) in 1st line NSCLC patients, no matter their level of PD-L1 expression, presented...

Continue reading

Clever Leaves Granted Brazilian GMP Certification for Cannabis Products by ANVISA

Multinational operator has been granted Brazilian GMP certification by ANVISA for the manufacturing of cannabis productsClever Leaves is the first and only medicinal cannabis company globally who has GMP certifications from the EU, Colombia and Brazil TOCANCIPÁ, Colombia, May 16, 2023 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, announced today that the Company has received the Brazilian GMP certification by ANVISA, the Brazilian Health Regulatory Agency, to manufacture cannabis products for Brazilian patients. Similar to the strict standards of the EU-GMP certification, ANVISA’s Brazilian-GMP certification ensures that patients receive the highest quality of medicine by preventing cases of product contamination, variations in compounds concentrations, mix-ups, incorrect...

Continue reading

Erasca Further Strengthens Business Leadership with Two Key Promotions

David Chacko, M.D., previously Erasca’s Chief Financial Officer, has been promoted to the dual position of Chief Financial Officer and Chief Business Officer Nik Chetwyn, Ph.D., previously Erasca’s SVP of Operations, has been promoted to Chief Operating Officer SAN DIEGO, May 16, 2023 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that David Chacko, M.D., previously chief financial officer (CFO) of Erasca, has been promoted to the dual position of CFO and chief business officer, and Nik Chetwyn, Ph.D., previously senior vice president of operations of Erasca, has been promoted to chief operating officer, with each promotion being effective as...

Continue reading

ABM Named a 2023 DiversityInc Noteworthy Company

NEW YORK, May 16, 2023 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), one of the nation’s largest providers of facility services, infrastructure solutions, and parking management, has been named to the DiversityInc list of Noteworthy companies for the first time. The DiversityInc Noteworthy Companies list is comprised of companies whose data indicates they have the potential to make the DiversityInc Top 50 list. “As home to more than 100,000 team members who serve more than 20,000 clients, ABM views diversity of backgrounds, perspectives, and experiences as a core part of our strength, both as an employer and industry leader,” said Scott Salmirs, President and CEO, ABM. “Driving diversity, equity, and inclusion (“DEI”) across every level of our organization is good for our people, our clients, our business, and our communities – and is simply...

Continue reading

EZ Funding Solutions Licenses Zerify’s Cyber Security Solutions to Safeguard Corporate and Customer Data

EDISON, N.J., May 16, 2023 (GLOBE NEWSWIRE) — Zerify Inc., (OTC PINK: ZRFY), the 22-year-old cybersecurity company focused on Secure Video Conferencing & Endpoint Security is proud to announce that EZ Funding Solutions, a prominent Business Finance Advisory company purchased a license for Zerify Meet™ with Zerify Defender™ to enhance data protection measures for EZ Funding Solutions and its valued corporate and customer data. “In these times, cyber security is critical, and therefore after learning about Zerify’s services, I signed up immediately for both Zerify Meet & Zerify Defender, keeping in mind that it gives me the peace of mind knowing that I have added level of protection,” says Parag Nevatia, CEO of EZ Funding Solutions. “To know that my data is protected 24/7 and my video calls are also shielded...

Continue reading

Identity and Access Management Provider BIO-key’s Q1 Revenue Rose 59% Driven by Growing Recurring Revenue Base and New Customer Wins; Investor Call 10am ET Today

WALL, N.J., May 16, 2023 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, today reported record quarterly revenue and improved bottom line results for its first quarter ended March 31, 2023 (Q1’23). BIO-key will host an investor call today at 10:00 a.m. ET (details below) to review its results and outlook. Highlights:Q1’23 revenues grew 59% to $3.1M, reflecting a growing base of high-margin, annual recuring revenue (ARRs) and new customer wins. Continued strength in higher education IAM deployments at colleges in California, Texas, Georgia and North Carolina. Government sector growth, including recent deployments in California, New York, North Carolina and Central America. Expanding...

Continue reading

LumiraDx Reports First Quarter 2023 Results

LONDON, May 16, 2023 (GLOBE NEWSWIRE) — LumiraDx Limited (NASDAQ: LMDX), a next-generation point of care (POC) diagnostics company, today announced financial results for its first quarter ended March 31, 2023.First quarter 2023 revenues of $22.2 million. Cost reduction programs implemented across the global organization resulting in declining operating losses. US Clinical Studies for first 510K submission completed. More than 100 customers in the first full launch quarter for the world’s first quantitative finger stick NT-proBNP assay.Ron Zwanziger, Chairman and CEO of LumiraDx, stated, “Our transition to non-COVID is beginning to develop, especially with the commercial launches of HbA1c and NT-proBNP on our Platform. Customer response continues to be positive, and we are collaborating with our key customers on use cases...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.